"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study

被引:29
作者
Dudgeon, Emily K. [1 ]
Crichton, Megan [2 ]
Chalmers, James D. [2 ]
机构
[1] Univ Dundee, Ninewells Hosp & Med Sch, Scottish Ctr Resp Res, Ninewells Dr, Dundee DD1 9SY, Scotland
[2] Univ Dundee, Div Mol & Clin Med, Dundee DD1 9SY, Scotland
来源
BMC PULMONARY MEDICINE | 2018年 / 18卷
关键词
Bronchiectasis; Symptoms; Endpoints; Questionnaires; Qualitative; CYSTIC FIBROSIS BRONCHIECTASIS; LEICESTER COUGH QUESTIONNAIRE; DOUBLE-BLIND; VALIDATION; EXACERBATIONS; AZITHROMYCIN; MORTALITY; IMPACT;
D O I
10.1186/s12890-018-0631-7
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Background: Bronchiectasis is a heterogeneous disease which affects quality of life. Measuring symptoms and quality of life has proved challenging and research is limited by extrapolation of questionnaires and treatments from other diseases. The objective of this study was to identify the major contributors to quality of life in bronchiectasis and to evaluate existing health related quality of life questionnaires in bronchiectasis. Methods: Eight adults with bronchiectasis participated in one to one semi-structured interviews. These were recorded and transcribed verbatim. Thematic analysis was used to identify core themes relevant to disease burden and impact. Participant views on current health related quality of life questionnaires were also surveyed. Results: Bronchiectasis symptoms are highly individual. Core themes identified were symptom burden, symptom variation, personal measurement, quality of life and control of symptoms. Themes contributing to quality of life were: social embarrassment, sleep disturbance, anxiety and modification of daily and future activities. Evaluation of 4 existing questionnaires established their individual strengths and weaknesses. A synthesis of the participants' perspective identified desirable characteristics to guide future tool development. Conclusions: This qualitative study has identified core themes associated with symptoms and quality of life in bronchiectasis. Current treatments and quality of life tools do not fully address or capture the burden of disease in bronchiectasis from the patients' perspective.
引用
收藏
页数:10
相关论文
共 32 条
  • [1] Research priorities in bronchiectasis: a consensus statement from the EMBARC Clinical Research Collaboration
    Aliberti, Stefano
    Masefield, Sarah
    Polverino, Eva
    De Soyza, Anthony
    Loebinger, Michael R.
    Menendez, Rosario
    Ringshausen, Felix C.
    Vendrell, Montserrat
    Powell, Pippa
    Chalmers, James D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 632 - 647
  • [2] Clinical phenotypes in adult patients with bronchiectasis
    Aliberti, Stefano
    Lonni, Sara
    Dore, Simone
    McDonnell, Melissa J.
    Goeminne, Pieter C.
    Dimakou, Katerina
    Fardon, Thomas C.
    Rutherford, Robert
    Pesci, Alberto
    Restrepo, Marcos I.
    Sotgiu, Giovanni
    Chalmers, James D.
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2016, 47 (04) : 1113 - 1122
  • [3] Effect of Azithromycin Maintenance Treatment on Infectious Exacerbations Among Patients With Non-Cystic Fibrosis Bronchiectasis The BAT Randomized Controlled Trial
    Altenburg, Josje
    de Graaff, Casper S.
    Stienstra, Ymkje
    Sloos, Jacobus H.
    van Haren, Eric H. J.
    Koppers, Ralph J. H.
    van der Werf, Tjip S.
    Boersma, Wim G.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 309 (12): : 1251 - 1259
  • [4] Validity of three asthma-specific quality of life questionnaires: the patients' perspective
    Apfelbacher, Christian J.
    Jones, Christina J.
    Frew, Anthony
    Smith, Helen
    [J]. BMJ OPEN, 2016, 6 (12):
  • [5] Aztreonam for inhalation solution in patients with non-cystic fibrosis bronchiectasis (AIR-BX1 and AIR-BX2): two randomised double-blind, placebo-controlled phase 3 trials
    Barker, Alan F.
    O'Donnell, Anne E.
    Flume, Patrick
    Thompson, Philip J.
    Ruzi, Jonathan D.
    de Gracia, Javier
    Boersma, Wim G.
    De Soyza, Anthony
    Shao, Lixin
    Zhang, Jenny
    Haas, Laura
    Lewis, Sandra A.
    Leitzinger, Sheila
    Montgomery, A. Bruce
    McKevitt, Matthew T.
    Gossage, David
    Quittner, Alexandra L.
    O'Riordan, Thomas G.
    [J]. LANCET RESPIRATORY MEDICINE, 2014, 2 (09) : 738 - 749
  • [6] Inhaled mannitol for non-cystic fibrosis bronchiectasis: a randomised, controlled trial
    Bilton, Diana
    Tino, Gregory
    Barker, Alan F.
    Chambers, Daniel C.
    De Soyza, Anthony
    Dupont, Lieven J. A.
    O'Dochartaigh, Conor
    van Haren, Eric H. J.
    Vidal, Luis Otero
    Welte, Tobias
    Fox, Howard G.
    Wu, Jian
    Charlton, Brett
    [J]. THORAX, 2014, 69 (12) : 1073 - 1079
  • [7] Development of a symptom specific health status measure for patients with chronic cough: Leicester Cough Questionnaire (LCQ)
    Birring, SS
    Prudon, B
    Carr, AJ
    Singh, SJ
    Morgan, MDL
    Pavord, ID
    [J]. THORAX, 2003, 58 (04) : 339 - 343
  • [8] Patient coping strategies in COPD across disease severity and quality of life: a qualitative study
    Brien, Sarah B.
    Lewith, George T.
    Thomas, Mike
    [J]. NPJ PRIMARY CARE RESPIRATORY MEDICINE, 2016, 26
  • [9] Lung function, symptoms and inflammation during exacerbations of non-cystic fibrosis bronchiectasis: a prospective observational cohort study
    Brill, Simon E.
    Patel, Anant R. C.
    Singh, Richa
    Mackay, Alexander J.
    Brown, Jeremy S.
    Hurst, John R.
    [J]. RESPIRATORY RESEARCH, 2015, 16
  • [10] The Bronchiectasis Severity Index An International Derivation and Validation Study
    Chalmers, James D.
    Goeminne, Pieter
    Aliberti, Stefano
    McDonnell, Melissa J.
    Lonni, Sara
    Davidson, John
    Poppelwell, Lucy
    Salih, Waleed
    Pesci, Alberto
    Dupont, Lieven J.
    Fardon, Thomas C.
    De Soyza, Anthony
    Hill, Adam T.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2014, 189 (05) : 576 - 585